The tariff classification of Cabazitaxel (CAS No. 183133-96-2) in bulk powder form, from Italy
Issued October 3, 2018 by U.S. Customs and Border Protection.
Tariff classification
HTS codes: 2932.99.6100
Headings: 2932
Product description
Cabazitaxel is an antineoplastic agent belonging to the taxane class. It is indicated in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer previously treated with a docetaxel-containing treatment regimen.
CBP rationale
The applicable subheading for Cabazitaxel in bulk form will be 2932.99.6100, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Heterocyclic compounds with oxygen hetero-atom(s) only: Other: Other: Aromatic: Other: Products described in additional U.
Full text
N300531 October 3, 2018 CLA-2-29:OT:RR:NC:N1:138 CATEGORY: Classification TARIFF NO.: 2932.99.6100 Ms. Sheila Heerdt Ren Pharm International Ltd. 350 Jericho Turnpike, Suite 204 Jericho, NY 11753 RE: The tariff classification of Cabazitaxel (CAS No. 183133-96-2) in bulk powder form, from Italy Dear Ms. Heerdt In your letter dated September 11, 2018, you requested a tariff classification ruling. Cabazitaxel is an antineoplastic agent belonging to the taxane class. It is indicated in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer previously treated with a docetaxel-containing treatment regimen. The applicable subheading for Cabazitaxel in bulk form will be 2932.99.6100, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Heterocyclic compounds with oxygen hetero-atom(s) only: Other: Other: Aromatic: Other: Products described in additional U.S. note 3 to section VI.” Pursuant to General Note 13, HTSUS, the rate of duty will be free. Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided on the World Wide Web at https://hts.usitc.gov/current. This merchandise may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at www.fda.gov. This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Judy Lee at [email protected]. Sincerely, Steven A. Mack Director National Commodity Specialist Division
More rulings on the same tariff codes
The tariff classification of Docetaxel (CAS No. 114977-28-5) in bulk powder form, from Canada
The tariff classification of Paclitaxel (CAS No. 33069-62-4) in bulk powder form, from Canada
The tariff classification of Luteolin, and Genistein from China
The tariff classification of Docetaxel (CAS No. 114977-28-5) in bulk powder form, from Italy
The tariff classification of 5-methoxy-6,6-dimethyl-3,4-diphenylcarbonyloxy-2H-3,4,5,6-tetrahydropyran-2-yl benzoate from China
The tariff classification of Paclitaxel (CAS No. 33069-62-4) in bulk powder form, from Italy
The tariff classification of Amiodarone Hydrochloride (CAS No. 19774-82-4) in bulk form, from France
Protest and Application for Further Review No. 2704-12-102569; Classification of Silymarin Powder
The tariff classification of Sertraline Hydrochloride (CAS 79559-97-0) and Amiodarone Hydrochloride (CAS 19774-82-4) in bulk form, from China
The tariff classification of Olopatadine Hydrochloride (CAS 140462-76-6) in bulk powder form, from Finland
Searching CBP rulings the smart way
TariffLens semantically searches all 200,000+ CBP rulings, surfaces the ones that actually match your product, and builds defensible classifications backed by ruling citations.
Book a demo →